A prospective multi-centre randomised, double-blind, active comparator-controlled, parallel-groups study coparing the fully human monoclonal anti-TNF-alpha antibody D2E7 with methotrexate and the combination of D2E7 and methotrexate in patients with early rheumatoid arthritis.

Starting date
February 9, 2001
Duration (months)
40
Departments
Medicine
Managers or local contacts
Bambara Lisa Maria

Sponsors:

Abbott sRL
Funds: assigned and managed by the department

Project participants

Collaboratori esterni

Paola Caramaschi
Azienda Ospedaliera di Verona Reumatologia Dirigente Medico I livello
Antonio Carletto
Azienda Ospedaliera di Verona Reumatologia Dirigente Medico I livello

Activities

Research facilities